Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

108 results about "D-mannitol" patented technology

Stabilized human monoclonal antibody preparation

A stabilized human monoclonal antibody preparation containing 1 to 20 mg of D-mannitol per 1 mg of a human monoclonal antibody. This preparation is excellent in stability in a solution state, a freeze drying state and a freezing state, particularly stability against aggregation and precipitation of the human monoclonal antibody at the time of redissolution after freeze drying.
Owner:HAGIWARA HIDEAKI

Plukenetia volubilis linneo health-care nougat

The invention discloses plukenetia volubilis linneo health-care nougat. The nougat comprises maltose syrup, white granulated sugar, ovalbumin, plukenetia volubilis linneo powder, diglycerol fatty acid ester, D-mannitol, banana resistant starch, trehalose, plukenetia volubilis linneo oil, edible essence, Pu-Er raw tea extract and water. The nougat is prepared by the following steps of: extruding plukenetia volubilis linneo kernels by a cold press to prepare the plukenetia volubilis linneo oil, crushing plukenetia volubilis linneo dregs into the plukenetia volubilis linneo powder by a low-temperature liquid nitrogen crushing technology, preparing the banana resistant starch by a spray drying technology, and mixing and boiling the nutrients including the trehalose, the plukenetia volubilis linneo oil, the plukenetia volubilis linneo powder, the banana resistant starch and the Pu-Er raw tea extract and other accessories. The nougat is stable in preservation, delicate in mouthfeel during eating, moderate in toughness, non-sticky, high in sweetness and low in calorie, has less possibility of softening, has the effects of clearing free radicals in body, improving the immunity of organism, regulating the level of blood sugar and the like, can prevent human osteoporosis and promote proliferation of human bifidobacteria, and is beneficial to gastrointestinal health.
Owner:普洱联众生物资源开发有限公司

Compound nutritious food capable of improving whole digestive tract

The invention provides compound nutritious food capable of improving the whole digestive tract. The compound nutritious food capable of improving the whole digestive tract is prepared from the following raw materials in parts by weight: 5-15 parts of xylooligosaccharide, 2-20 parts of fructo-oligosaccharide, 3-20 parts of isomaltooligosaccharide, 3-30 parts of stachyose, 5-20 parts of inulin, 6-20 parts of concentrated whey protein, 1-15 parts of chitosan oligosaccharide, 0.5-10 parts of saccharomyces boulardii powder and 0.5-15 parts of lactobacillus plantarum powder; and according to dosage form requirements, the compound nutritious food capable of improving the whole digestive tract also comprises the following auxiliary materials in parts by weight: 10-80 parts of maltodextrin, 5-20 parts of D-mannitol, 0.5-1.5 parts of guar gum, 0.5-1 part of citric acid and 0.3-1 part of silicon dioxide, wherein the preservation number of lactobacillus plantarum is CGMCC NO.11763. The compound nutritious food provided by the invention has the advantages that high-performance dominant probiotics and multiple nutrient substances are comprehensively utilized and combined, the whole digestive tract is improved, microecological balance in the human body is kept by regulating gastrointestinal florae, and further food digestion and nutrition absorption are promoted, growth of harmful bacteria and toxin in the digestive tract is inhibited and diseases of the digestive tract are prevented, so that comprehensive improvement of health condition of the digestive tract and significant enhancement of immunity of the organism are realized.
Owner:北京东方兴企食品工业技术有限公司

Astaxanthin and hippophae rhamnoides fruit powder tabletting sweets and preparation method thereof

The invention discloses astaxanthin and hippophae rhamnoides fruit powder tabletting sweets and a preparation method thereof. The tabletting sweets are prepared from the following raw materials and auxiliary materials in parts: 30-50 parts of astaxanthin, 30-250 parts of hippophae rhamnoides fruit powder, 90-250 parts of beta-cyclodextrin, 30-300 parts of D-mannitol, 1-12 parts of citric acid, 1-150 parts of microcrystalline cellulose, 6-12 parts of calcium chloride, and 1-10 parts of magnesium stearate. According to the astaxanthin and hippophae rhamnoides fruit powder tabletting sweets disclosed by the invention, through experiments, a formula proportion of the astaxanthin to the hippophae rhamnoides fruit powder, an embedding proportion of the astaxanthin to an embedding medium, an addition amount of correctant citric acid and the like are preferably selected, and appropriate technological parameters are also preferably selected, so that antioxidative activity in the astaxanthin and the hippophae rhamnoides fruit powder is reserved to the maximum extent, and a strong antioxidative function that the function of the tabletting sweets is better than the function of the astaxanthin and the function of the hippophae rhamnoides fruit powder is generated, and the problem that the mouth feel is poor is solved.
Owner:SHANDONG JINHE DRUG RES DEV

Composition containing lutein and lutein ester, pressed lutein candy, preparation method and application

The invention discloses a composition containing lutein and lutein ester, pressed lutein candy, a preparation method and application. The composition comprises lutein, lutein ester, zeaxanthin, blueberry powder, natural carotene, trehalose, D-mannitol and the like. The composition is used for preparing the pressed lutein candy, and the preparation method comprises the steps of embedding natural carotene and the like, mixing the natural carotene with remaining materials except trehalose and D-mannitol, and pulverizing and sieving the mixture to obtain powder; using the powder as a core material, coating the core material with a wall material solution, and conducting granulating, drying, tabletting and coating to obtain a final product. According to the method, specific components and content are combined together, and therefore the absorption dose demanded by the human body can be achieved; each component plays a good synergistic role in eye protection; through a specific technologicalprocess, the final product is stable and has a slow release function, correspondingly people can effectively and continuously absorb effective components, and the problem of absorption limitation is solved.
Owner:四川益康天成生物科技开发有限公司 +1

Multi-vitamin calcium-zinc chewable tablets and preparation method thereof

The invention relates to multi-vitamin calcium-zinc chewable tablets which are prepared from povidone K30, zinc gluconate, sucralose, calcium hydrogen phosphate, L-calcium lactate, D-mannitol, folic acid, vitamins, D-calcium pantothenate, lactose, nicotinamide, strawberry essence and magnesium stearate. More specifically, the multi-vitamin calcium-zinc chewable tablets provided by the invention are vitamin B tablets; compared with common vitamin B chewable tablets which are added with some trace elements that the human body lacks and need to be supplemented by food, a simple preparation can replace the preparations such as vitamin B, calcium tablets and zinc gluconate oral liquid while supplementing vitamin B, calcium and zinc; moreover, the preparation technology is simple and easy to implement, the product performance is stable, the production cost is relative low, and the effect of the product is relatively obvious.
Owner:海南金贝康制药有限公司

Natural type oil-water compatible edible essence and preparation method thereof

The invention relates to a natural type oil-water compatible edible essence and a preparation method thereof. The natural type oil-water compatible edible essence has oil solubility and water solubility and is prepared by uniformly mixing and dissolving following components in parts by weight: 5-10 parts of limonene, 10-20 parts of glycerol, 5-10 parts of phospholipid, 1.5-2.5 parts of D-mannitol, 1-2 parts of polydextrose and 2-4 parts of maltitol. According to the product, the adopted main material limonene is produced from natural tangerine and orange peels and dreg, is natural, has no stimulation and has a lasting aroma; the raw materials are recyclable and renewable and wide in sources so that wastes are changed into valuable things. The edible essence has many functions, a sweet taste and good biological degradability; the manufacturing process is simple, the operation is convenient, the conditions of a production environment are not strict, and no pollution is caused; special equipment and a matched pollution discharging facility are not needed and the practical value and the economic benefit are obvious. The use amount of the product can be adjusted according to an actual production condition; the seasoning effect is very good and the quality guaranteeing time is long; the natural type oil-water compatible edible essence is convenient to transport and storage, can be widely applied to food processing fields of candies, bakery products, beverages and the like, and is convenient to use.
Owner:TIANJIN LIUHONG TECH DEV

Tabletted sweets capable of alleviating asthenopia as well as preparation method and application of tabletted sweets

The invention relates to the technical field of foods, and discloses tabletted sweets capable of alleviating asthenopia. The tabletted sweets comprise the following raw materials in parts by weight: 40-50 parts of blueberry fruit juice powder, 1-5 parts of chrysanthemum powder, 20-30 parts of Chinese wolfberry fruit powder, 1-5 parts of grape seeds, 0.1-1 part of xanthophyll, 5-10 parts of dietaryfibers, 10-20 parts of D-mannitol, 5-10 parts of maltodextrin and 0.1-1 part of magnesium stearate. The invention further discloses a preparation method of the tabletted sweets and an application ofthe tabletted sweets in the respect of alleviating asthenopia. The tabletted sweets have the beneficial effects of being comprehensive in nutrient components, an original ecology low-temperature processing technology is adopted, the tabletted sweets conform to the proportion of promoting blood circulation for removing blood stasis, nourishing liver and kidney and removing liver fire for improvingeyesight in traditional Chinese medicines, and nutrient components of the raw materials are guaranteed not to be destroyed, so that the efficacy of promoting blood circulation for removing blood stasis and removing liver fire for improving eyesight can be achieved.
Owner:江苏海王健康生物科技有限公司

Vitamin C effervescent tablet

The present invention relates to an effervescent tablet, and particularly relates to a vitamin C effervescent tablet. The invention belongs to the technical field of health food tablet formulation. Vitamin C, one of the essential vitamins of the human body, has a preventive effect on many diseases. Vitamin C can also be used in combination with many other drugs in the treatment of certain diseases. Effervescent tablet is a novel tablet developed and applied abroad in recent years, and the effervescent tablet is usually prepared by acid and alkali separate wet granulation, followed by being mixed with other raw materials for tablet compressing. In order to shorten the production process and further improve the product stability, the invention adopts the mixed use of alpha- and beta-crystalform D-mannitol, which reduces the fragility of the tablets on the basis of ensuring the effervescent effect of the tablets. The formula of the invention is suitable for the direct tablet compressingprocess, free of the addition of water or other wetting agents in the production process and capable of reducing the occurrence of material pollution, improving the production efficiency, reducing theprocess flow and decreasing and reducing the energy consumption. In addition, the addition of sodium caseinate can improve the effervescent effect of the tablets.
Owner:SHANDONG TIANLI PHARMA

Peptide pharmaceutical formulations

A pharmaceutical composition for administration to a mammal is disclosed. The composition includes a therapeutically effective amount of a peptide, such as a GLP-1 molecule, a PTH molecule, or a GRF molecule. The composition further includes a buffer including a weak acid having an acid dissociation constant value of greater than about 1×10−5, such as acetic acid. The composition also includes an excipient for making the composition generally isotonic, such as D-mannitol.
Owner:JEFFERSON PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products